Systane Complete PF
Drug
Alcon Research LLC
Total Payments
$246,084
Transactions
4
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $246,084 | 4 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $246,084 | 4 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Effects of artificial tears on lipid films and tear dynamics in vivo | Alcon Research LLC | $90,521 | 0 |
| Effects of artificial tears on tear lipid films and tear film dynamics in vivo | Alcon Research LLC | $90,521 | 0 |
| How does Systane COMPLETE PF impact functional visual acuity, measured in real-time between blinks, in dry eye patients | Alcon Research LLC | $46,636 | 0 |
| Understanding Quality of Life in High Digital Device Users who are Treated with Systane Complete PF | Alcon Research LLC | $18,406 | 0 |
Top Doctors Receiving Payments for Systane Complete PF
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Andover, MA | $246,084 | 4 |
Ad
Manufacturing Companies
- Alcon Research LLC $246,084
Product Information
- Type Drug
- Total Payments $246,084
- Total Doctors 0
- Transactions 4
About Systane Complete PF
Systane Complete PF is a drug associated with $246,084 in payments to 0 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. The primary manufacturer is Alcon Research LLC.
Payment data is available from 2023 to 2023. In 2023, $246,084 was paid across 4 transactions to 0 doctors.
The most common payment nature for Systane Complete PF is "Unspecified" ($246,084, 100.0% of total).
Systane Complete PF is associated with 4 research studies, including "Effects of artificial tears on lipid films and tear dynamics in vivo" ($90,521).